MedTrace Logo

Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany

NCT05319925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 213

Last updated 2023-12-15

No results posted yet for this study

Summary

This study aims to develop and to validate a standardised German-language instrument for measuring experienced financial effects of a cancer diagnosis and therapy in a cross-sectional bi-centre study. Obtained data will make the patient-related description of financial difficulties more comprehensible, communicable and addressable in the future, e.g. by offering targeted advisory aids or considering financial effects in health technology assessments.

Conditions

Interventions

OTHER

Patient reported outcome measure

Newly developed patient-reported instrument to measure financial effects of a cancer diagnosis and therapy of cancer patients in Germany

Sponsors & Collaborators

  • Chair of Methods in Empirical Social Research, Institute of Sociology, Technische Universität Dresden

    collaborator UNKNOWN

  • Health Economics and Health Care Management, Bielefeld University

    collaborator UNKNOWN

  • Haematology and Oncology, University of Jena

    collaborator UNKNOWN

  • University Hospital Heidelberg

    lead OTHER

Principal Investigators

  • Eva C Winkler, Prof. Dr. Dr. · National Center for Tumor Diseases, University Hospital Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-07-31
Completion
2023-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05319925 on ClinicalTrials.gov